ClinVar Miner

Submissions for variant NM_000558.5(HBA1):c.84G>T (p.Glu28Asp)

dbSNP: rs41530750
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000507741 SCV000601199 uncertain significance not provided 2020-08-04 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories RCV001000510 SCV001157415 likely benign not specified 2019-02-26 criteria provided, single submitter clinical testing The Hb Hekinan II variant (HBA1: c.84G>T; p.Glu28Asp, also known as Glu27Asp when numbered from the mature protein, rs41530750) is described in the literature as a non-pathogenic variant observed in heterozygous individuals without clinical symptoms and with normal hematology (Yao 2013, HbVar database). When observed in individuals with alpha globin deletions (--SEA deletion, -3.7 deletion), Hb Hekinan II is not associated with a worsening of clinical symptoms or more severe hematological parameters (Chunpanich 2004, Fucharoen 2003, Ngiwsara 2004). This variant is reported in ClinVar (Variation ID: 15742) and is found on only two chromosomes in the Genome Aggregation Database. The glutamate at codon 28 is highly conserved, but computational analyses (SIFT: damaging, PolyPhen-2: benign) predict conflicting effects of this variant on protein structure/function. Based on available information, the Hb Hekinan II variant is considered to be likely benign. References: HbVar link to Hb Hekinan II: Chunpanich S et al. Laboratory diagnosis of a compound heterozygosity for Hb Hekinan [alpha27(B8) Glu-Asp] and a deletional alpha-thalassaemia 2 in Thailand. Clin Lab Haematol. 2004 Oct;26(5):355-8. Fucharoen S et al. Complex interaction of Hb Hekinan [alpha27(B8) Glu-Asp] and Hb E [beta26(B8) Glu-Lys] with a deletional alpha-thalassemia 1 in a Thai family. Eur J Haematol. 2003 May;70(5):304-9. Ngiwsara L et al. Two cases of compound heterozygosity for Hb Hekinan [alpha27(B8)Glu-->Asp (alpha1)] and alpha-thalassemia in Thailand. Hemoglobin. 2004 May;28(2):145-50. Yao XY et al. Prevalence and genetic analysis of a-thalassemia and beta-thalassemia in Chongqing area of China. Gene. 2013 Dec 10;532(1):120-4.
OMIM RCV000017047 SCV000037319 other HEMOGLOBIN HEKINAN 2016-07-20 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.